Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-07-31
2007-07-31
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S629000
Reexamination Certificate
active
10735487
ABSTRACT:
The novel glucocorticoid receptor antagonists are 11β-substituted steroid compounds of formula (I):wherein R1denotes a methyl group, a methoxy group, or an ethoxy group; wherein R2denotes a tert.-butyl group, a 1-hydroxy-1-methylethyl group, a 1-methoxy-1-methylethyl group, an ethyl isocrotonate group, or a substituted phenyl group. The method of treating an individual suffering from glucocorticoid-mediated hypogonadism, sexual dysfunctions, and/or infertility includes administering a daily dosage consisting of an effective amount of one of these 11β-substituted steroid compounds.
REFERENCES:
patent: 4477445 (1984-10-01), Philibert et al.
patent: 5620966 (1997-04-01), Gebhard et al.
patent: 6072068 (2000-06-01), Groen et al.
patent: 0 057 115 (1985-03-01), None
patent: 0 683 172 (1995-11-01), None
patent: 0 793 541 (1999-09-01), None
patent: 95/04536 (1995-02-01), None
patent: WO 95/04536 (1995-02-01), None
patent: 96/20795 (1996-07-01), None
patent: 01/47859 (2001-07-01), None
Moguilewsky, M. Philibert et al: “The Antiprogestin Steroid . . . ” p. 87-97, Plenum Press, New York, London 1984.
Lynnette K. Nieman et al: “Successful Treatment of Cushing's Syndrome . . . ”, J. Clin. Endorc. Metab. 6, vol. 1, p. 536-540, 1985.
R. Gebhard et al: “11.21-Bisphenyl-19-Norpregnane . . . ”, Bioorganic & Medicinal Chemistry Letters 7, pp. 2229-2234, 1997.
Pharmabusiness 21, p. 152, 2002.
Bothe Ulrich
Hillisch Alexander
Kaufmann Guenter
Patchev Vladimir
Schubert Gerd
Badio Barbara P.
Bayer Schering Pharma AG
Striker Michael J.
LandOfFree
Glucocorticoid receptor antagonists for prophylaxis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid receptor antagonists for prophylaxis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid receptor antagonists for prophylaxis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767022